(CIDRAP News) Norwegian scientists today reported a pandemic H1N1 virus mutation that appears to be associated with severe disease, but a leading US flu expert said global data on the mutation don't show a clear connection with severe illness.
(CIDRAP News) Decreasing pandemic flu activity and growing supplies of vaccine offer a window of opportunity for people to protect themselves from the virus, especially if the nation experiences a third wave of infections, Thomas Frieden, MD, director of the US Centers for Disease Control and Prevention (CDC) said today.
(CIDRAP News) Pandemic H1N1 influenza activity is showing further signs of declining around the country but remains very widespread, the Centers for Disease Control and Prevention (CDC) reported today.
Norway OKs OTC antiviral salesTo ease response to the H1N1 pandemic, Norway is allowing over-the-counter sales of oseltamivir (Tamiflu) and zanamivir (Relenza), the Associated Press (AP) reported. The new policy starts tomorrow and is in effect until the middle of 2010. Norway has ordered 9.4 million doses of vaccine, but the manufacturer has reportedly not produced enough to meet demand.